M&A/IPOs

 

Spanish hospital M&A resumes in July

Spain's private hospital groups have resumed their pre-COVID M&A binge in July, with three of the five largest striking deals to acquire smaller competitors. It comes as private hospital activity levels across Europe recover more quickly than previously forecast - although that hasn't prevented casualties amongst some individual sites.

Orpea kickstarts €1.5bn propco sell-off with Icade deal

Europe's largest elderly care operator Orpea is preparing to strike more sale-and-leaseback deals with big REITs after concluding a €145m deal with Icade in Germany. HBI expects a flurry of deals may follow as part of a £1.5bn propco sell-off which will fuel further acquisitions. We talk to property investment sources about where else it might sell, potential buyers and the yields they can expect.

Elsan confirms KKR deal

France's second-largest private hospital operator Elsan has confirmed recent reports that global private equity firm KKR is acquiring a stake in the group, and is being joined by French investor Ardian.

Fortis asks Supreme Court to unblock sale to IHH

Could the end of the Fortis Healthcare sale saga finally be in sight? Fortis has asked the Indian Supreme Court to allow IHH to finally start its open offer, nearly two years after the acceptance period was due to start.

Zur Rose buys TeleClinic

Zur Rose Group, Europe's largest online pharmacy group, has bought German telehealth player TeleClinic for a "mid-double digit million" price tag.

FocusCura acquired by Swedish locksmith conglomerate

Netherlands-based elderly tech solutions developer FocusCura has been bought by listed Swedish conglomerate ASSA ABLOY around 18 months after spinning off its telemonitoring app Luscii into a separate subsidiary. The €20bn market-cap 'access solutions' firm is a curious buyer but it tells HBI that the acquisition creates opportunities to develop further products for elderly care.

Circle divests to get BMI deal through

UK private hospital operator Circle Health is to divest its Bath and Birmingham hospitals to get competition watchdog approval for its buyout of larger competitor BMI Healthcare.

Find Us